Risk factors for outcome and mortality in hospitalized geriatric patients with SARS-CoV-2 infection Data from a hospital of maximum care during in the period of the second corona wave 2020/2021 in Germany

被引:0
|
作者
Doerr, Stefan [1 ,2 ]
Joachim, Regina [1 ]
Chatzitomaris, Apostolos [1 ]
Lobmann, Ralf [1 ]
机构
[1] Klinikum Landeshauptstadt Stuttgart gKAoR, Krankenhaus Bad Cannstatt, Klin Endokrinol Diabetol & Geriatrie, Stuttgart, Germany
[2] Klinikum Landeshauptstadt Stuttgart gKAoR, Krankenhaus Bad Cannstatt, Klin Endokrinol Diabetol & Geriatrie, Priessnitzweg 24, D-70374 Stuttgart, Germany
来源
关键词
Infection; Hospitalisation; Dementia; Neuroleptic drugs; Intensiv care; COVID-19;
D O I
10.1007/s00391-023-02161-8
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: From autumn 2020 until spring 2021 Germany experienced the second wave of SARS-CoV-2 infections. As in the previous wave, the older population in nursing homes was hard hit by this infection because of the lack of available vaccines. Due to the multimorbidity in this susceptible group the mortality was high.Methods: Retrospectively collected patient data of geriatric patients treated from 1 October 2020 to 31 March 2021 due to proven SARS-CoV-2 infection were evaluated concerning the duration of symptoms, hospital stay, and laboratory results. The results are presented descriptively and significance tests were performed with t-test and log-rank test to reveal some risk factors for a worse outcome.Results: A total of 168 patients aged from 65 to 97 years were included, with a mean mortality rate of 28% and was highest in the age group over 90 years old. Most patients died within the first 10 days of hospitalization. Intensive care treatment prolonged the hospital stay by 6 days, but the average survival time became equal at the end. Risk factors for worse outcome and the need of intensive care treatment were neutrophilia, lymphopenia, high levels of ferritin and high D-dimer levels on the day of admission. Age, short duration of symptoms and pre-existing dementia, administration of neuroleptic drugs and antidepressants increased the risk of death.
引用
下载
收藏
页码:118 / 124
页数:7
相关论文
共 43 条
  • [41] Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study
    Wong, Carlos K. H.
    Au, Ivan C. H.
    Lau, Kristy T. K.
    Lau, Eric H. Y.
    Cowling, Benjamin J.
    Leung, Gabriel M.
    LANCET, 2022, 400 (10359): : 1213 - 1222
  • [42] Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)
    Daniele Zama
    Francesco Baccelli
    Antonella Colombini
    Amalia Contino
    Elisabetta Calore
    Maria Grazia Petris
    Linda Meneghello
    Federico Mercolini
    Andrea Lo Vecchio
    Shana Montalto
    Cristina Meazza
    Angelica Barone
    Francesca Compagno
    Paola Muggeo
    Elena Soncini
    Letizia Brescia
    Eugenia Giraldi
    Nagua Giurici
    Rosa Maria Mura
    Monica Cellini
    Katia Perruccio
    Valeria Petroni
    Milena La Spina
    Ottavio Ziino
    Roberta Burnelli
    Raffaella De Santis
    Maurizio Mascarin
    Valentina Barretta
    Gloria Tridello
    Simone Cesaro
    Annals of Hematology, 2022, 101 : 1843 - 1851
  • [43] Favorable outcome of SARS-CoV-2 infection in pediatric hematology oncology patients during the second and third pandemic waves in Italy: a multicenter analysis from the Infectious Diseases Working Group of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)
    Zama, Daniele
    Baccelli, Francesco
    Colombini, Antonella
    Contino, Amalia
    Calore, Elisabetta
    Petris, Maria Grazia
    Meneghello, Linda
    Mercolini, Federico
    Lo Vecchio, Andrea
    Montalto, Shana
    Meazza, Cristina
    Barone, Angelica
    Compagno, Francesca
    Muggeo, Paola
    Soncini, Elena
    Brescia, Letizia
    Giraldi, Eugenia
    Giurici, Nagua
    Mura, Rosa Maria
    Cellini, Monica
    Perruccio, Katia
    Petroni, Valeria
    La Spina, Milena
    Ziino, Ottavio
    Burnelli, Roberta
    De Santis, Raffaella
    Mascarin, Maurizio
    Barretta, Valentina
    Tridello, Gloria
    Cesaro, Simone
    ANNALS OF HEMATOLOGY, 2022, 101 (08) : 1843 - 1851